Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

9.130 -0.170 (-1.83%)

Delayed Quote Updated: 12:54 PM EST, Nov 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

33 34 Next >

Compass Pathways Research Suggests Psilocybin Can Treat Anorexia

May 12, 2022

Via Investor Brand Network

Psychedelic Stock Gainers And Losers From May 11, 2022 ↗

May 11, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS:

Via Benzinga

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021 ↗

May 11, 2022

Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or...

Via Benzinga

Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗

May 10, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26

Via Benzinga

Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs ↗

May 10, 2022

Psychedelics policy action took center stage this week.

Via Benzinga

Compass Pathways: Q1 Earnings Insights ↗

May 10, 2022

Compass Pathways (NASDAQ:CMPS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space ↗

May 10, 2022

The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”...

Via Benzinga

Psychedelic Stock Gainers And Losers From May 9, 2022 ↗

May 09, 2022

GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34

Via Benzinga

A Preview Of Compass Pathways's Earnings ↗

May 09, 2022

Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Compass...

Via Benzinga

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults ↗

May 09, 2022

Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on...

Via Benzinga

Psychedelic Stocks Continue To Decline In May ↗

May 08, 2022

The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.

Via Talk Markets

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 06, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Via Benzinga

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

May 05, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 04, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30

Via Benzinga

2 New Studies Look At Compass Pathways' Psilocybin Drug For Anorexia And Depression ↗

May 03, 2022

Compass Pathways (Nasdaq: CMPS), a company developing psychedelic pharmaceutical drugs for the mental health space, announced the publication of two new investigator-initiated studies using its...

Via Benzinga

Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 03, 2022

GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 02, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Via Benzinga

Transcript: Jason Raznick's Conversation with Mr. Wonderful Kevin O'Leary At The Benzinga Psychedelics Conference ↗

May 02, 2022

On this special edition of the RazReport, Benzinga Founder & CEO Jason Raznick sits down with Kevin O'Leary AKA Mr. Wonderful at the Benzinga Psychedelics Capital...

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

April 29, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:

Via Benzinga

Landmark Gathering Of Psychedelics Executives And Scientists To Take Place In London May 11 ↗

April 28, 2022

As the field of psychedelic medicine moves forward and international borders begin to open up, an expanding offering of conferences and live events are becoming available for investors, industry people...

Via Benzinga

Psychedelic Stock Gainers And Losers From April 28, 2022 ↗

April 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20

Via Benzinga

Oregon to Become the First State to Legally Roll Out Psilocybin

April 28, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...

Via FinancialNewsMedia

Topics Derivatives ETFs

Psychedelic Stock Gainers And Losers From April 27, 2022 ↗

April 27, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 26, 2022 ↗

April 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 25, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 22, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29

Via Benzinga

Psychedelic Stock Gainers And Losers From April 20, 2022 ↗

April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Via Benzinga

Compass Pathways Partners With One Mind To Fund Rising Star Awards ↗

April 20, 2022

Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.